日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Longitudinal increase of humoral responses after four SARS-CoV-2 vaccinations and infection in MS patients on fingolimod

芬戈莫德治疗的多发性硬化症患者在接种四剂SARS-CoV-2疫苗和感染后,体液免疫反应纵向增强

van Kempen, Zoé LE; van Dam, Koos Pj; Keijser, Jim Bd; Stalman, Eileen W; Kummer, Laura Yl; Strijbis, Eva Mm; Steenhuis, Maurice; Ten Brinke, Anja; van Ham, S Marieke; Kuijpers, Taco; Rispens, Theo; Eftimov, Filip; Wieske, Luuk; Killestein, Joep

Impact of serum neurofilament light on clinical decisions in a tertiary multiple sclerosis clinic

血清神经丝轻链对三级多发性硬化症诊所临床决策的影响

van Lierop, Zoë Ygj; Wessels, Mark Hj; Lekranty, Womei Ml; Moraal, Bastiaan; Hof, Sam N; Hogenboom, Laura; de Jong, Brigit A; Meijs, Nandi; Mensing, Liselore A; van Oosten, Bob W; Sol, Nik; van Kempen, Zoé LE; Vermunt, Lisa; Willems, Myrthe J; Strijbis, Eva Mm; Uitdehaag, Bernard Mj; Killestein, Joep; Teunissen, Charlotte E

Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patients

血清神经丝轻链和胶质纤维酸性蛋白水平与接受那他珠单抗治疗的多发性硬化症患者的疗效减退症状无关

Toorop, Alyssa A; Wessels, Mark Hj; Boonkamp, Lynn; Gelissen, Liza My; Hoitsma, E; Zeinstra, Esther Mpe; van Rooij, Luuk C; van Munster, Caspar Ep; Vennegoor, Anke; Mostert, Jop P; Wokke, Beatrijs Ha; Kalkers, Nynke F; Hoogervorst, Erwin Lj; van Eijk, Jeroen Jj; Roosendaal, Christiaan M; Kragt, Jolijn J; Eurelings, Marijke; van Genugten, Jessie; Nielsen, Jessica; Sinnige, Lgf; Kloosterziel, Mark E; Arnoldus, Edo Pj; van Dijk, Gert W; Bouvy, Willem H; Strijbis, Eva Mm; van Oosten, Bob W; de Jong, Brigit A; Uitdehaag, Bernard Mj; Rispens, Theo; Killestein, Joep; van Kempen, Zoé LE; Teunissen, Charlotte E

Aging is associated with reduced inflammatory disease activity independent of disease duration in relapsing multiple sclerosis trial populations

在复发型多发性硬化症试验人群中,衰老与炎症性疾病活动性降低相关,且与疾病持续时间无关。

Coerver, Eline Me; Kaçar, Sezgi; Ciccarelli, Olga; Sormani, Maria P; Barkhof, Frederik; Arnold, Douglas L; Schoonheim, Menno M; Van Kempen, Zoé LE; Mostert, Jop; Koch, Marcus W; Killestein, Joep; Eshaghi, Arman; Uitdehaag, Bernard Mj; Strijbis, Eva Mm

Disease progression in the first 5 years of treatment in multiple sclerosis: Predictive value of early brain and lesion volume changes

多发性硬化症治疗前 5 年的疾病进展:早期脑和病变体积变化的预测价值

Rozemarijn M Mattiesing, Eline Kramer, Eva Mm Strijbis, Iman Brouwer, Ronald A van Schijndel, Giordano Gentile, Marco Battaglini, Nicola De Stefano, Bernard Mj Uitdehaag, Frederik Barkhof, Hugo Vrenken, Menno M Schoonheim

Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light

纳他珠单抗治疗复发缓解型多发性硬化症患者的血清胶质纤维酸性蛋白:神经丝轻链的替代指标

Wessels, Mark Hj; Van Lierop, Zoë Ygj; Noteboom, Samantha; Strijbis, Eva Mm; Heijst, Johannes A; Van Kempen, Zoé LE; Moraal, Bastiaan; Barkhof, Frederik; Uitdehaag, Bernard Mj; Schoonheim, Menno M; Killestein, Joep; Teunissen, Charlotte E

Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic

在新冠疫情期间,针对多发性硬化症患者采用个性化B细胞剂量方案治疗奥瑞珠单抗。

van Lierop, Zoë Ygj; Toorop, Alyssa A; van Ballegoij, Wouter Jc; Olde Dubbelink, Tom Bg; Strijbis, Eva Mm; de Jong, Brigit A; van Oosten, Bob W; Moraal, Bastiaan; Teunissen, Charlotte E; Uitdehaag, Bernard Mj; Killestein, Joep; Kempen, Zoé LE van

The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials

MSIS-29 和 SF-36 作为继发进展型多发性硬化症试验的结局指标

Strijbis, Eva Mm; Repovic, Pavle; Mostert, Jop; Bowen, James D; Uitdehaag, Bernard Mj; Cutter, Gary; Koch, Marcus W

Functional brain network organization measured with magnetoencephalography predicts cognitive decline in multiple sclerosis

利用脑磁图测量的功能性脑网络组织可以预测多发性硬化症患者的认知能力下降

Nauta, Ilse M; Kulik, Shanna D; Breedt, Lucas C; Eijlers, Anand Jc; Strijbis, Eva Mm; Bertens, Dirk; Tewarie, Prejaas; Hillebrand, Arjan; Stam, Cornelis J; Uitdehaag, Bernard Mj; Geurts, Jeroen Jg; Douw, Linda; de Jong, Brigit A; Schoonheim, Menno M

Resting-state MEG measurement of functional activation as a biomarker for cognitive decline in MS

静息态脑磁图测量功能激活作为多发性硬化症认知衰退的生物标志物

Schoonhoven, Deborah N; Fraschini, Matteo; Tewarie, Prejaas; Uitdehaag, Bernard Mj; Eijlers, Anand Jc; Geurts, Jeroen Jg; Hillebrand, Arjan; Schoonheim, Menno M; Stam, Cornelis J; Strijbis, Eva Mm